Clinical Trials Logo

Catheter-Related Infections clinical trials

View clinical trials related to Catheter-Related Infections.

Filter by:

NCT ID: NCT05441605 Completed - Clinical trials for Catheter-Associated Infections

Effect of Chlorhexidine Solution in Preventing Peripheral Venous Catheter Associated-Infection

Start date: June 24, 2022
Phase: N/A
Study type: Interventional

This research aims to determine the most effective chlorhexidine concentration to be used in preventing peripheral venous catheter-associated infections. This research is a randomized controlled double-blinded experimental design. This research will conduct between July 2022-June 2023 with 96 intensive care patients at a state hospital in Turkey. The study sample consist of 96 new insertions of peripheral venous catheters.The study will carried out as a experimental trial to compare the efficacy 1%, 2% and 4% clorhexidine gluconate and 70% alcohol in preventing infections due to catheter administrations in patients. Patients who fulfilled the inclusion criteria is randomized according to the randomization programme into three experimental groups and the control group. "Patient Information Form", "Catheter Information Form" and "Observational Form" will used to collect data.The vital findings and local infection findings of the patients that peripheral venous catheter is inserted will followed and recorded at pre-insertion and once every 24 hours for 96 hours. Culture analyze will performed from swab example taken from catheter entry location at pre-insertion,1st hour and pre removal of catheter.Data will analyzed in statistical program and p<0,05 will considered as significant.

NCT ID: NCT05139628 Not yet recruiting - Clinical trials for Catheter-Related Infections

Peripheral Venous Catheter Related Blood Stream Infections

Start date: July 1, 2023
Phase:
Study type: Observational

The aim of this work is to: 1. Study the impact of PIVC skin colonization on catheter tip colonization and the development of CRBSI 2. isolate and identify the organisms causing peripheral venous catheter related blood stream infections in pediatric oncology patients. 3. perform antimicrobial sensitivity testing of isolated organisms. 4. identify the associated risk factors that lead to CRBSIs in such group of patients.

NCT ID: NCT04920877 Not yet recruiting - Catheter Infection Clinical Trials

Preventing Central Catheter-Associated Bloodstream Infections

Start date: June 4, 2021
Phase: N/A
Study type: Interventional

The research is an algorithm study focused on nursing care in order to prevent Central Catheter-Associated Bloodstream Infections in intensive care units. The algorithm prepared with infection control measures related to central catheter care will be applied with intensive care nurses and the effect of the algorithm on central catheter-related bloodstream infections will be examined. In practice, a 20-day preliminary assessment, a three-month intervention period, and a three-month post-intervention planning were made.

NCT ID: NCT04906512 Terminated - Clinical trials for Catheter-Related Infections

Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy

Start date: May 14, 2021
Phase: N/A
Study type: Interventional

This is a single-center, prospective, randomized controlled clinical trial designed to compare the antimicrobial efficacy of Tegaderm CHG I.V. Securement Dressing and transparent dressings for deep vein catheterization in adult ICU patients.

NCT ID: NCT04825314 Recruiting - Infection Clinical Trials

Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization

Start date: May 21, 2020
Phase: N/A
Study type: Interventional

Eighty percent of nosocomial UTI caused by indwelling urinary catheters and so known-as catheter-associated UTI. CAUTI leads to multiple local and systemic derangements such as suprapubic pain, dysuria, cystitis, pyelonephritis, septicemia, and even septic shock. This study will be conducted up on 100 patients (50 per each group) with long term catheterization to assess efficacy of noble metal alloy coated catheter in reducing CAUTI.

NCT ID: NCT04821193 Completed - Nursing Caries Clinical Trials

Comparison of the Effects of 5%NaHCO3, 2%CHG and 70%Alcohol in the Prevention of Infections Related to Catheter

Start date: November 7, 2017
Phase: N/A
Study type: Interventional

Intravenous catheters have become one of the indispensable tools of modern medicine. Peripheric intravenous catheters facilitate the work of healthcare professionals in the treatment phase, especially in diagnostic procedures. Intravenous catheters cause microorganisms to enter the bloodstream by damaging the skin, which is the body's first defense barrier. In this case, it causes infections, sepsis, an increase in mortality and morbidity rates, prolongation of hospital stay, increase in antibiotic use, and medical expenses. The density of the skin flora in the area where the catheter will be inserted is a major risk factor for infection.To prevent complications associated with peripheric intravenous catheters; Performing the procedure in line with the principles of surgical asepsis and following the correct follow-up are among the most important measures that the nurse should take. Also, the child and the parents should be prepared for the procedure and the appropriate environment should be provided. Along with correct catheter placement and care, antisepsis of the cannula placement area is among the indicators of nursing care. As well as the effectiveness and safety of skin disinfectants, topical absorption, lack of toxic effect, local and irritation effect are also important. Solutions with 5% NaHCO3 have recently come to the fore as antiseptic agents. When the literature is examined, it has not been found that there are very few studies on this solution and it is used in skin antisepsis before peripheral intravenous catheterization in children. This study was planned as a randomized controlled experimental design to determine the effectiveness of 5% NaHCO3 water solution in catheter site cleaning in pediatric patients by comparing it with the most commonly used antiseptic agents and to monitor the development of catheter-related infections.

NCT ID: NCT04794231 Completed - Clinical trials for Catheter-Related Infections

Comparison of Chlorhexidine Impregnated Dressing and Standard Dressing

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Investigators have designed a single-center randomized controlled trial to compare chlorhexidine gluconate (CHG)-impregnated dressing and standard dressing with respect to their effects on the infection outcomes. The study was condcuted in the pediatric intensive care unit in the 18 months period.

NCT ID: NCT04787926 Terminated - Clinical trials for Catheter-Related Infections

DuraLock-C Catheter Lock Solution

Start date: September 23, 2021
Phase:
Study type: Observational

To evaluate the safety and performance of DuraLock-C 4.0%, 30.0%, and 46.7% for the maintenance of central venous catheter (CVC) patency in adult hemodialysis (HD) patients

NCT ID: NCT04772209 Completed - Clinical trials for Catheter-Related Infections

Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

In our study, investigators will investigate the effectiveness and complications of two catheter lock solutions one of which is the standard heparin routinely used in comparison to Sodium bicarbonate. Both solutions were used but not compared head to head. Investigators aim to compare both solutions in terms of catheter lumen patency and their effect on catheter-related infections.

NCT ID: NCT04534348 Completed - Clinical trials for CLABSI - Central Line Associated Bloodstream Infection

Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps

STERILE
Start date: November 1, 2017
Phase:
Study type: Observational

Observational study on the reduction of catheter-related Infections by use of self-disinfecting venous and arterial access caps (Curos caps ;3M, Saint Paul, MN, USA)